IFN-α in Relapse Prevention.

Clinical trial NCT07449286 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07449286
Sponsor: Peking University People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2026-03-01
Primary completion: 2026-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.